Intouch Solutions

JANUARY 6, 2021

Amazon Pharmacy’s debut is worrying many, but its long-terms effect on pharma marketing remains uncertain. Read on to learn more about Amazon’s “master plan,” and whether your brand needs to consider a defensive strategy. The post Amazon Pharmacy: How Will It Affect Pharma? appeared first on Intouch Solutions.

Pharmacy 52

Pharmacy Branding Marketing 52

Pharmaceutical Technology

MARCH 8, 2023

Lilly has claimed that a major obstacle to insulin price reduction has been due to pharmacy benefit manager formularies and contracts with insurance providers, and that list prices for insulin have to remain high for insulin to remain on these formularies.

Insulin 264

Insulin Branding Marketing Pharmacy 264

World of DTC Marketing

OCTOBER 4, 2021

Earlier this year, I was asked by a client to write a position paper on using Facebook for the DTC marketing of an oncology product. From my estimates, most of it failed because pharma companies are afraid of misinformation concerning regulations around DTC marketing. Bob Hoffman. When will Facebook be held accountable?

Branding 224

Branding Marketing Pharmacy Pharma Companies 224

STAT News

DECEMBER 5, 2022

In the fight to command the growing market for telehealth, Thirty Madison is staking out new terrain. Over the last year and a half, the 5-year-old digital health startup has been quietly planning to expand into sleep care with a new brand called River.

Marketing 98

Marketing Allergies Pharmacy Branding 98

Pharmacy Checkers

NOVEMBER 19, 2020

Forgetting about the potential dangers to competition from corporate Leviathan Amazon, that it launched a new online pharmacy this week will certainly appeal to tens of millions of Americans. But, unlike in many other industries where Amazon can crush the competition on prices, its online pharmacy launch does not accomplish that.

Pharmacy 52

Pharmacy Insulin Branding Generic Drugs 52

Pharmaceutical Technology

FEBRUARY 3, 2023

However, after almost seven years of staving off competitors through patents and litigation, Humira’s market-leading position in the US will be affected as Amgen’s adalimumab biosimilar, Amjevita, started to roll out on January 31, 2023. According to GlobalData estimates, in 2022, the adalimumab biosimilars market was valued at $184.2

Marketing 130

Marketing Sales Pharmacy Branding 130

Pharmacy Checkers

FEBRUARY 14, 2020

Joe and Teresa Graedon, founders of The People’s Pharmacy , not only have an admirable track record of telling health consumers how it is, but also listening to those in their readership. Many readers complained that it just wasn’t cutting it compared to the brand name version. Just switch back to the brand!”

Branding 62

Branding FDA Approval Pharmacy Bioequivalency 62

BioPharma Reporter

NOVEMBER 20, 2023

At last monthâs CPHI Barcelona, Sirio launched its new ready-to-market menopause and eye health softgels in a bid to collaborate with over the counter (OTC) brands and large pharmacy chains looking to advance to market faster.

Pharmacy 52

Pharmacy Branding Marketing Development 52

Drug Channels

MARCH 5, 2024

WHAT YOU WILL LEARN In 2023, the Inflation Reduction Act of 2022 (IRA) began to alter the Medicare Part D program and trigger changes in beneficiary out-of-pocket spending, drug prices, pharmacy economics, and market access strategies. Pharmacies and Pharmacy Benefit Managers.

Drugs 83

Drugs Pharmacy Marketing Branding 83

Pharmaceutical Technology

APRIL 19, 2023

PharmaChoice, which has more than 1,000 independent pharmacy owners and operators under its brand, will run MedX’s technology at 20 locations across the four provinces over a three-month assessment period. Telehealth is on the rise , with its market expected to be worth $3.8bn by 2030, according to GlobalData.

Dermatology 130

Dermatology Pharmacy Branding Marketing 130

Drug Channels

APRIL 4, 2023

Time for Drug Channels Institute’s annual update on the gross-to-net bubble —the ever-growing dollar gap between sales at brand-name drugs' list prices and their sales at net prices after rebates and other reductions. We estimate that the gross-to-net bubble reached $223 billion for patent-protected brand-name drugs in 2022.

Marketing 56

Marketing Branding Sales Pharmacy 56

Drug Channels

JUNE 21, 2023

Time for Drug Channels Institute’s annual update on the gross-to-net bubble —the ever-growing dollar gap between sales at brand-name drugs' list prices and their sales at net prices after rebates and other reductions. We estimate that the gross-to-net bubble reached $223 billion for patent-protected brand-name drugs in 2022.

Marketing 59

Marketing Branding Sales Pharmacy 59

Intouch Solutions

MARCH 2, 2022

My second favorite thing about pharmaceutical marketing is the wonderful customer complexity (the first, of course, is that we can use our marketing superpowers for good not evil). The labyrinth of customers, each with different and often contradictory needs, makes Rx marketing a game of three-dimensional chess.

Marketing 52

Marketing Branding Sales Pharmacy 52

World of DTC Marketing

JUNE 22, 2022

Generic drugs versus branded is also a considerable expense. But Express Scripts, which manages pharmacy benefits for 100 million people, is telling pharmacies to dispense the more expensive Advair brand because it won’t cover Mylan’s generic.

Pharmacy 227

Pharmacy Generic Drugs Life Science Branding 227

pharmaphorum

APRIL 1, 2022

market is just beginning to heat up. Semglee (insulin glargine-yfgn) is the first biosimilar available at the retail pharmacy counter, and it obtained interchangeable status. Innovator products working to maintain market share. In the latter half of 2021, there was lots of exciting movement.

Marketing 57

Marketing Pharmacy FDA Approval Manufacturing 57

pharmaphorum

FEBRUARY 24, 2021

2021 will be the year when big market access changes – including the far wider use of health economic evaluation – are implemented in Spain. In the latest of a suite of features looking at the biggest markets in Europe, Leela Barham takes stock of what 2021 could bring for market access in Spain. Higher biosimilar savings.

Marketing 98

Marketing Pharmacy Medicine Branding 98

Drug Channels

AUGUST 13, 2021

Today’s guest post comes from Stacey Little, Senior Vice President of Business Development and Marketing at AssistRx. Stacey discusses how a patient support vendor can help specialty pharmacy patients attain prior authorizations and access critical therapies.

Branding 54

Branding Pharmacy Business Development Manufacturing 54

pharmaphorum

JANUARY 8, 2021

The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. With medical staff working tirelessly and lockdown restrictions in place across the world, the way pharma markets medications has changed, too.

Marketing 98

Marketing Doctors Doctor Pharma Companies 98

Druggist

MARCH 23, 2021

In recent months, ibuprofen’s price went up significantly, with many shops and pharmacies being out of stock of ‘cheap’ ibuprofen. Firstly, I will discuss the availability of branded ibuprofen. Ibuprofen alternatives – branded ibuprofen 200mg. Other brands of ibuprofen 200mg. Summary: What is ibuprofen?

Drugs 92

Drugs Pharmacy Branding Containment 92

Drug Channels

OCTOBER 23, 2023

A program driven by market dynamics and led by champions of channel strategy, join now to master the complexities of pharmacy and distribution models to accelerate market access –It's all happening December 11-13, 2023. Why should you attend this pivotal event? How is health policy affecting the distribution channel?

Pharmacy 60

Pharmacy Marketing Production Branding 60

Pharma Mirror

JANUARY 24, 2023

Neuraxpharm Belgium will be based in Brussels and will distribute and market prescription brand The post Neuraxpharm completes its presence in Benelux appeared first on Pharma Mirror Magazine.

Branding 130

Branding Marketing Pharmacy 130

Pharmaceutical Technology

JUNE 12, 2023

The over-the-counter (OTC) marketing authorisation for the gel as a de novo medical device means the FDA has followed suit after the treatment received CE marking in Europe and UKCA marking in the UK in 2021 and 2022, respectively. The addition of a topical gel to pharmacy shelves expands treatment options available to those with ED.

FDA Approval 130

FDA Approval Pharmacy Marketing Branding 130

Drug Channels

FEBRUARY 23, 2021

In this issue: Payers confess: Patients lose from copay accumulators Humana joins the Express Scripts GPO Hospitals vs. PBMs over specialty pharmacy white bagging Let’s all follow the Buy-and-Bill Dollar! Plus, entrepreneurial pharmacy owner Dave Marley demonstrates the power of innovation. More to come. Marley Drug generated $1.7

Pharmacy 52

Pharmacy Drugs Generic Drugs Production 52

World of DTC Marketing

OCTOBER 25, 2021

In addition to immediate access to a physician, they offer on-site labs to analyze blood, MRI and CAT scan machines, pharmacies, and a full range of OTC products. In my opinion, these total urgent care centers will be springing up throughout the US and could even be branded under retailers like Wal*Mart or Target.

Containment 257

Containment Branding Pharmacy Production 257

Pharmaceutical Technology

MARCH 24, 2023

Amgen’s (US) Amjevita (adalimumab) is the first Humira biosimilar, launched in February 2023, and seven other FDA-approved biosimilars are expected to arrive on the US market later this year. AbbVie had reached settlement agreements with the biosimilar manufacturers to keep the biosimilars off the US market until 2023.

FDA Approval 147

FDA Approval Marketing Manufacturing Sales 147

World of DTC Marketing

JULY 27, 2022

A drug’s out-of-pocket cost is primarily the result of decisions made by insurance companies and pharmacy benefit managers (PBMs). In 2021 pharma provided a staggering $204 billion in price concessions for brand-name medicines to PBMs. The problem is that PBMs are out for themselves and shareholders, not patients.

Pharmacy 226

Pharmacy Generic Drugs Medicine Drugs 226

Pharmaceutical Technology

JULY 15, 2022

Nothing epitomises market failures more than the cost of insulin,” Newsom said in a video posted on Twitter. Most of the US insulin market is controlled by three pharma companies: Sanofi, Eli Lilly, and Novo Nordisk. The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin.

Insulin 328

Insulin Manufacturing Contract Manufacturing Production 328

pharmaphorum

JUNE 6, 2022

American entrepreneur and investor Mark Cuban tells us why he and his partners launched the Mark Cuban Cost Plus Drug Company (MCCPDC), a public-benefit corporation and online pharmacy that provides patients access to medications at a lower cost. . We want to work with every source of medications, branded or generic.”

Drugs 144

Drugs Manufacturing Pharmacy Branding 144

pharmaphorum

DECEMBER 18, 2022

Patient access solutions, including hubs and specialty pharmacies, play a vital role in getting patients started on therapy. Additionally, with traditional solutions, brands are hurt by misaligned incentives that drive low adherence and diminished gross-to-net. The current inefficient patient access models are better than none at all.

Branding 98

Branding Pharmacy Life Science Nurses 98

Intouch Solutions

JUNE 6, 2023

In 2022, approximately 80% of all prescription drug claims were processed by three pharmacy benefit managers (PBMs)/group purchasing organization (GPOs): Express Scripts and Ascent Health, OptumRx and Emisar Pharmacy Solutions, and CVS Caremark and Zinc Health Services.

Pharmacy 52

Pharmacy Marketing Branding Drugs 52

Drug Channels

NOVEMBER 8, 2021

Year after year, the life science industry marks Informa Connect’s Trade and Channel Strategies as the “go-to” event for trade, channel, market access, account strategy and brand professionals. Drug Channels readers will save 10% off the current registration rate when they use promo code 10DC21*.

Pharmacy 68

Pharmacy Life Science Branding Marketing 68

Druggist

DECEMBER 28, 2020

The Government recently announced the reclassification of fexofenadine 120mg, which will be available as General sale Medication (GSL), sold as branded products – Allevia 120mg tablets. Most manufactures of other antihistamines available in pharmacies and shops advice to avoid taking antihistamines during pregnancy. cetirizine.

Pharmacy 98

Pharmacy Doctors Doctor Allergies 98

Fossil Remedies

NOVEMBER 22, 2022

If you are a budding entrepreneur who wants to launch a business of your own, then opening a pharmaceutical marketing firm could be a better choice. The prerequisites to becoming successful in a pharma franchise business are your predictability and supervision of the market. Selection of brand. Wide range of products.

Branding 52

Branding Pharma Production Production Marketing 52

Drug Channels

JUNE 5, 2023

View the Agenda Snapshot Enhance Patient Service, Network Design, and Channel Strategies to Improve Patient Access and Support In its 8th year, the Specialty Network and Patient Support Services Summit is an important event for senior leaders in patient access, trade, channel, market access, brand and account strategy.

Pharmacy 53

Pharmacy Gene Therapy Manufacturing Compliance 53

Pharmacy Checkers

JANUARY 10, 2020

A friend of mine, who has very difficult to control cholesterol, was prescribed Livalo, an FDA-approved brand of the drug pitavastatin. He went to our site to discover that brand-name Livalo ( pitavastatin ). He went to our site to discover that brand-name Livalo ( pitavastatin ). pharmacies. Let’s call him John.

FDA Approval 62

FDA Approval Branding Pharmacy Manufacturing 62

Pharma Marketing Network

MARCH 3, 2021

Here, we offer four ways pharma marketers can help. In the initial flurry of adapting, brands quickly augmented their plans to drive large-scale messages to patients and prospects: how to access telehealth, insurance coverage, and more. Language has always been important to marketers. Reassess the Patient Journey.

Branding 88

Branding Marketing Pharmacy Research 88

World of DTC Marketing

FEBRUARY 21, 2022

A new study estimates the causal effects of coupons for branded drugs without bioequivalent generics using variation in coupon introductions over time and comparing differential responses across enrollees in commercial and Medicare Advantage plans.

Regulation 218

Regulation Drugs Bioequivalency Pharmacy 218